ES3049333T3 - Compounds for the treatment of respiratory diseases - Google Patents

Compounds for the treatment of respiratory diseases

Info

Publication number
ES3049333T3
ES3049333T3 ES18795097T ES18795097T ES3049333T3 ES 3049333 T3 ES3049333 T3 ES 3049333T3 ES 18795097 T ES18795097 T ES 18795097T ES 18795097 T ES18795097 T ES 18795097T ES 3049333 T3 ES3049333 T3 ES 3049333T3
Authority
ES
Spain
Prior art keywords
mmol
sup
nmr
mhz
solvate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES18795097T
Other languages
English (en)
Spanish (es)
Inventor
Spencer Williams
Sayali Shah
Zalihe Hakki
Alastair Stewart
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Tianli Biotech Pty Ltd
Original Assignee
Tianli Biotech Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2017901611A external-priority patent/AU2017901611A0/en
Application filed by Tianli Biotech Pty Ltd filed Critical Tianli Biotech Pty Ltd
Application granted granted Critical
Publication of ES3049333T3 publication Critical patent/ES3049333T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
ES18795097T 2017-05-03 2018-05-03 Compounds for the treatment of respiratory diseases Active ES3049333T3 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AU2017901611A AU2017901611A0 (en) 2017-05-03 Compounds for the treatment of respiratory diseases
AU2017901647A AU2017901647A0 (en) 2017-05-05 Compounds for the treatment of respiratory diseases
PCT/AU2018/050404 WO2018201192A1 (en) 2017-05-03 2018-05-03 Compounds for the treatment of respiratory diseases

Publications (1)

Publication Number Publication Date
ES3049333T3 true ES3049333T3 (en) 2025-12-16

Family

ID=64015663

Family Applications (1)

Application Number Title Priority Date Filing Date
ES18795097T Active ES3049333T3 (en) 2017-05-03 2018-05-03 Compounds for the treatment of respiratory diseases

Country Status (9)

Country Link
US (2) US20200079757A1 (cg-RX-API-DMAC7.html)
EP (1) EP3619204B1 (cg-RX-API-DMAC7.html)
JP (2) JP7788128B2 (cg-RX-API-DMAC7.html)
CN (1) CN110753688A (cg-RX-API-DMAC7.html)
AU (3) AU2018262108A1 (cg-RX-API-DMAC7.html)
ES (1) ES3049333T3 (cg-RX-API-DMAC7.html)
FI (1) FI3619204T3 (cg-RX-API-DMAC7.html)
PT (1) PT3619204T (cg-RX-API-DMAC7.html)
WO (1) WO2018201192A1 (cg-RX-API-DMAC7.html)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016149756A1 (en) 2015-03-23 2016-09-29 The University Of Melbourne Treatment of respiratory diseases
AU2019374731B2 (en) * 2018-11-07 2025-08-21 Tianli Biotech Pty Ltd Compounds and compositions for the treatment of respiratory diseases
CN110452880B (zh) * 2019-09-09 2021-09-21 温州医科大学附属第一医院 急性肺损伤细胞模型的制备方法及其应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5593991A (en) * 1993-07-16 1997-01-14 Adams; Jerry L. Imidazole compounds, use and process of making
US5593992A (en) * 1993-07-16 1997-01-14 Smithkline Beecham Corporation Compounds
IL110296A (en) * 1993-07-16 1999-12-31 Smithkline Beecham Corp Imidazole compounds process for their preparation and pharmaceutical compositions containing them
IL118544A (en) * 1995-06-07 2001-08-08 Smithkline Beecham Corp History of imidazole, the process for their preparation and the pharmaceutical preparations containing them
JP2001526230A (ja) * 1997-12-19 2001-12-18 スミスクライン・ビーチャム・コーポレイション ヘテロアリール置換イミダゾール化合物、その医薬組成物および使用
MX2012004997A (es) * 2009-10-28 2012-06-12 Pfizer Derivados de imidazol como inhibidores de la caseina quinasa.
CZ2012538A3 (cs) * 2012-08-08 2014-02-19 Masarykova Univerzita Inhibitory pro léčbu B-buněčné chronické lymfocytární leukémie
WO2016149756A1 (en) 2015-03-23 2016-09-29 The University Of Melbourne Treatment of respiratory diseases

Also Published As

Publication number Publication date
JP7788128B2 (ja) 2025-12-18
JP2023134493A (ja) 2023-09-27
JP2020518621A (ja) 2020-06-25
US20200079757A1 (en) 2020-03-12
EP3619204A1 (en) 2020-03-11
PT3619204T (pt) 2025-10-29
CN110753688A (zh) 2020-02-04
AU2024200521B2 (en) 2025-10-02
EP3619204A4 (en) 2021-03-24
AU2024200521A1 (en) 2024-02-15
US20220380343A1 (en) 2022-12-01
EP3619204B1 (en) 2025-10-01
AU2018262108A1 (en) 2019-11-21
AU2022202774A1 (en) 2022-05-19
WO2018201192A1 (en) 2018-11-08
FI3619204T3 (fi) 2025-11-06

Similar Documents

Publication Publication Date Title
US12215095B2 (en) Compounds for the treatment of respiratory diseases
ES2700542T3 (es) Composición farmacéutica que comprende un derivado de pirazolo[1,5-A]pirimidina como un agente antiviral
AU2024200521B2 (en) Compounds for the treatment of respiratory diseases
CN107847480B (zh) 呼吸性疾病的治疗
CN104854105B (zh) 具有毒蕈碱受体拮抗剂和β2肾上腺素能受体激动剂活性的化合物
CN111620815B (zh) 手性氯喹、羟氯喹和其衍生物及其制备方法与用途
HK40023875B (en) Compounds for the treatment of respiratory diseases
HK40023875A (en) Compounds for the treatment of respiratory diseases
HK40058742A (en) Treatment of respiratory diseases
HK40059876A (en) Treatment of respiratory diseases
HK40096728B (en) Compounds and methods for treatment of viral infections